Elutia (ELUT) Cash & Current Investments (2019 - 2026)
Elutia (ELUT) reported Cash & Current Investments of $28.5 million for Q1 2026, up 64.12% on a YoY basis from $17.4 million in Q1 2025, and down 21.63% sequentially from $36.4 million in Q4 2025.
Elutia (ELUT) Cash & Current Investments (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Cash & Current Investments data on file, last reported at $28.5 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 64.12% year-over-year to $28.5 million; the trailing twelve-month figure through Mar 2026 stood at $28.5 million (up 64.12% YoY), and the FY2025 full-year result was $36.4 million, up 174.57% from the prior year.
- Cash & Current Investments retreated to $28.5 million in Q1 2026, from $36.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $36.4 million in Q4 2025 to a low of $4.7 million in Q3 2025.
- A 5-year average of $16.7 million and a median of $16.5 million in 2022 frame the typical range for Cash & Current Investments.
- Peak annual rise in Cash & Current Investments reached 174.57% in 2025, while the deepest fall reached 81.66% in 2025.
- Tracing ELUT's Cash & Current Investments over 5 years: stood at $17.0 million in 2022, then climbed by 13.46% to $19.3 million in 2023, then tumbled by 31.32% to $13.2 million in 2024, then soared by 174.57% to $36.4 million in 2025, then dropped by 21.63% to $28.5 million in 2026.
- Business Quant data shows ELUT's Cash & Current Investments at $28.5 million in Q1 2026, $36.4 million in Q4 2025, and $4.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.80 Bn | 125.92 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.37 Bn | 44.70 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.41 Bn | 27.30 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Elutia | 40.03 Mn | 11.54 Mn | 1.80 Mn | 28.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.49 Mn |
| Dec 31, 2025 | 36.35 Mn |
| Sep 30, 2025 | 4.72 Mn |
| Jun 30, 2025 | 8.50 Mn |
| Mar 31, 2025 | 17.36 Mn |
| Dec 31, 2024 | 13.24 Mn |
| Sep 30, 2024 | 25.74 Mn |
| Jun 30, 2024 | 18.19 Mn |
| Mar 31, 2024 | 12.55 Mn |
| Dec 31, 2023 | 19.28 Mn |
| Sep 30, 2023 | 14.52 Mn |
| Jun 30, 2023 | 9.30 Mn |
| Mar 31, 2023 | 11.79 Mn |
| Dec 31, 2022 | 16.99 Mn |
| Sep 30, 2022 | 8.10 Mn |
| Jun 30, 2022 | 16.51 Mn |
| Mar 31, 2022 | 22.18 Mn |
| Dec 31, 2021 | 30.43 Mn |
| Sep 30, 2021 | 22.63 Mn |
| Jun 30, 2021 | 28.37 Mn |